Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Protagen

Request full access

A provider of services, products and software solutions for protein research

Dortmund, GermanyFounded 1997Biotech & Life Sciences

About Protagen

Protagen AG is a specialty diagnostic company that has been developing advanced diagnostic tools, with a particular focus on autoimmune diseases and immuno-oncology. The company was founded in 1997 by Dr. Christoph Hüls, Dr. Peter Schulz-Knappe, and Dr. Michael Wandνομα.

The company's core technology revolves around its SeroTag® biomarker platform, which is used to develop powerful diagnostic tests. This platform aids in the differential diagnosis of autoimmune diseases that have complex and overlapping symptoms, such as rheumatoid arthritis. By identifying disease-specific autoantibodies, Protagen's tools enable earlier and more precise diagnoses, which can lead to better patient outcomes. For instance, their technology can help differentiate rheumatoid arthritis from other inflammatory joint diseases.

In the realm of immuno-oncology, Protagen has worked on identifying biomarkers that can predict a patient's response to cancer immunotherapies. This is a critical area in cancer treatment, as it helps clinicians select the most effective therapies for individual patients, moving towards a more personalized medicine approach. This capability allows for the stratification of patients in clinical trials and the development of companion diagnostics.

Protagen was acquired by the Oncimmune Holdings plc in 2019 for £5.7 million. This acquisition integrated Protagen's biomarker discovery capabilities, particularly in autoimmune diseases, with Oncimmune's focus on cancer diagnostics and immunotherapy. Following the acquisition, the German operations continued in Dortmund.

Source: Dealroom company data

Protagen in the Dortmund ecosystem

Live from Dealroom

The Protagen office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Venture Capital Dortmund
  • MIG Capital
  • KfW
  • NRW.BANK

Series B and later1 investor entered at this stage

  • Qiagen
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇩🇪 Germany · Dortmund HQ
Book a demo for the full country breakdown

See Protagen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.